Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.8150 (-1.73%) ($10.8150 - $10.8150) on Mon. Aug. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.06% (three month average) | RSI | 46 | Latest Price | $10.8150(-1.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(32%) VUG(31%) XLK(31%) VT(30%) BLOK(28%) | Factors Impacting BCRX price | BCRX will decline at least -2.03% in a week (0% probabilities). UUP(-15%) VIXM(-13%) SMH(-7%) EDOC(-5%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.03% (StdDev 4.06%) | Hourly BBV | -0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.35 | 5 Day Moving Average | $10.94(-1.14%) | 10 Day Moving Average | $11.18(-3.26%) | 20 Day Moving Average | $11.35(-4.71%) | To recent high | -10.5% | To recent low | 37.9% | Market Cap | $1.908b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |